High expression levels of pyrimidine metabolic rate–limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets

Reprogramming of metabolism is described in many types of cancer and is associated with the clinical outcomes. However, the prognostic significance of pyrimidine metabolism signaling pathway in lung adenocarcinoma (LUAD) is unclear. Using the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiwei, Wang, Xinrui, Xu, Liangpu, Zhang, Ji, Cao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524999/
https://www.ncbi.nlm.nih.gov/pubmed/32638267
http://dx.doi.org/10.1007/s11302-020-09711-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524999/
https://www.ncbi.nlm.nih.gov/pubmed/32638267
http://dx.doi.org/10.1007/s11302-020-09711-4

Ejemplares similares